RRx-001 interacts with C409 of NLRP3 and suppresses the interaction of NLRP3 with NEK7, thereby inhibiting inflammasome assembly and alleviating symptoms in various disease models, including systemic inflammation, colitis, and experimental autoimmune encephalomyelitis in mice [376]. This evidence concerns the gene NLRP3 and colitis.